Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,734Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Janssen Pharmaceutica (Pty) Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ibrutinib

Brand Name : IMBRUVICA® 140 mg

Dosage Form : FCT

Dosage Strength : 140mg

Packaging : 30X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ibrutinib

Brand Name : IMBRUVICA® 420 mg

Dosage Form : FCT

Dosage Strength : 420mg

Packaging : 30X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ibrutinib

Brand Name : IMBRUVICA® 560 mg

Dosage Form : FCT

Dosage Strength : 560mg

Packaging : 30X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ibrutinib

Brand Name : Imbruvica 140 mg

Dosage Form : CAP

Dosage Strength : 140mg

Packaging : 120X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Ibrutinib

Brand Name : Imbruvica 140 mg

Dosage Form : CAP

Dosage Strength : 140mg

Packaging : 90X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank